orkshop 3 rd Edition Innovation in HIV and Viral Hepatitis Preliminary Programme

Transcription

1 3 rd Edition Preliminary Programme Call deadline December 9, 2014 for Abstract orkshop Scientific Coordinators Antonella d Arminio Monforte (Milan, I) Carlo Federico Perno (Rome, I) Massimo Puoti (Milan, I) Milan, Italy Palazzo delle Stelline January 26-27, 2015

2 orkshop Scientific Coordinators Antonella d Arminio Monforte San Paolo Hospital, Carlo Federico Perno University of Tor Vergata, Rome I Massimo Puoti Niguarda Ca Granda Hospital, Milan I Honorary President Mauro Moroni Professor Emeritus, Scientific Secretariat Francesca Ceccherini-Silberstein University of Tor Vergata, Rome I Giulia Marchetti San Paolo Hospital, Roberto Rossotti Niguarda Ca Granda Hospital, Milan I Milan, Italy January 26-27, 2015

3 Faculty Alessio Michele Aghemo Foundation IRCCS Maggiore Hospital, Massimo Andreoni University of Tor Vergata, Rome I Gioacchino Angarano University Hospital of Bari I Mario Angelico University of Tor Vergata, Rome I Andrea Antinori IRCCS - INMI Lazzaro Spallanzani, Rome I Stefano Bonora University of Turin I Raffaele Bruno University of Pavia I Savino Bruno Fatebenefratelli Hospital, University Milan Bicocca, Milan I Giampiero Carosi Professor Emeritus, University of Brescia I Antonella Castagna San Raffaele Scientific Institute, Milan I Dario Cattaneo San Paolo Hospital, Francesca Ceccherini-Silberstein University of Tor Vergata, Rome I Massimo Colombo Foundation IRCCS Maggiore Hospital, Andrea Cossarizza University Hospital of Modena and Reggio Emilia, Modena I Antonella d Arminio Monforte San Paolo Hospital, Gabriella d Ettorre University Hospital Umberto I, Rome I Andrea De Luca Siena University Hospital, Siena I Andrea De Maria University of Genoa, IRCCS AOU San Martino - IST Genoa I Giovanni Di Perri University of Turin I Daniel C. Douek Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda USA Carlo Ferrari University Hospital of Parma I Courtney V. Fletcher University of Nebraska Medical Center, College of Pharmacy, Omaha USA Charles W. Flexner Johns Hopkins University, Baltimore USA Giovanni Battista Gaeta Second University of Naples I Massimo Galli Luigi Sacco Hospital, Alessia Maria Giorgini San Paolo Hospital, Enrico Girardi IRCCS - INMI Lazzaro Spallanzani, Rome I Andrea Gori San Gerardo Hospital, Monza I Peter Hunt University of California, San Francisco USA Giuseppe Ippolito IRCCS - INMI Lazzaro Spallanzani, Rome I Paul Klenerman Nuffield Department of Medicine, University of Oxford UK Adriano Lazzarin University Vita-Salute San Raffaele, Milan I Michael M. Lederman Case Western Reserve University School of Medicine, University Hospitals/ Case Medical Center, Cleveland USA Massimo Levrero Sapienza University, Rome I Miriam Lichtner Sapienza University of Rome, Polo Pontino, Latina I Giulia Marchetti San Paolo Hospital, Fabio Marra University of Florence I Claudio Maria Mastroianni Sapienza University of Rome, Polo Pontino, Latina I Gabriele Missale University Hospital of Parma I Mauro Moroni Professor Emeritus, Carlo Federico Perno University of Tor Vergata, Rome I Massimo Pinzani Institute for Liver and Digestive Health, University College London, Royal Free Hospital, London UK Teresa Maria Pollicino G. Martino University Hospital, Messina I Massimo Puoti Niguarda Ca Granda Hospital, Milan I Giovanni Raimondo University Hospital of Messina I Giuliano Rizzardini Luigi Sacco Hospital, Teresa Antonia Santantonio University Hospital of Foggia I Annalisa Saracino University Hospital of Bari I Guido Silvestri Emory University School of Medicine, Yerkes National Primate Research Center, Atlanta USA Mario Strazzabosco University Milan Bicocca, Milan I Valentina Svicher University of Tor Vergata, Rome I Gloria Taliani Sapienza University, Rome I Camilla Tincati San Paolo Hospital, Erica Villa University of Modena and Reggio Emilia, Modena I Massimo Zuin San Paolo Hospital,

4 orkshop January 26, Welcome addresses A. d Arminio Monforte, C.F. Perno, M. Puoti OPENING LECTURE Innovation in medicine: where we are going? G. Ippolito Discussion LECTURE Conveners: M.M. Lederman, M. Moroni Framing the problem M.M. Lederman HIV pathogenesis G. Silvestri SESSION 1 Mechanisms of viral persistence: what role for the virus and what for the host? Conveners: G. Di Perri, M. Strazzabosco Framing the problem C.F. Perno HIV What obstacles for the cure? The host vs the virus D.C. Douek HCV Why the virus becomes chronic? P. Klenerman HBV Why the virus becomes chronic? T.M. Pollicino Discussion A.M. Aghemo, A. Cossarizza Lunch SESSION 2 Oral communications based on selected abstracts Conveners: S. Bruno, C.M. Mastroianni

5 Preliminary Programme January 26, SESSION 3 Beyond viral undetectability in plasma: which markers of therapy outcome Conveners: M. Colombo, G. Rizzardini HIV Case presentation and open questions HIV case presentation G. d Ettorre Open questions P. Hunt HCV Case presentation and open questions HCV case presentation F. Ceccherini-Silberstein Open questions M. Zuin HBV Case presentation and open questions HBV case presentation V. Svicher Open questions G. Raimondo Discussion A. Gori SESSION 4 Eradication and functional cure: pharmacology Conveners: A. Antinori, G. Carosi Framing the problem A. Antinori Insight the HIV reservoirs C.V. Fletcher Insight the HCV-related cirrhosis F. Marra Long-Acting injectable ARVs: dream or reality? C.W. Flexner Insight the HBV reservoirs M. Levrero Discussion D. Cattaneo Milan, Italy January 26-27, 2015

6 orkshop January 27, LECTURE Conveners: G.B. Gaeta, A. Lazzarin Impact of HIV & HCV viral burden at population level: what strategies to contain epidemics? E. Girardi Discussion LECTURE Conveners: G. Angarano, M. Galli CCR5 and modulation of fibrosis progression in HIV/HCV coinfection R. Bruno Discussion SESSION 5 Difficult to treat patients: what therapeutic strategy? Conveners: M. Andreoni, G. Missale Framing the problem M. Andreoni High HIV viremia: case presentation and open questions Does more aggressive anti HIV therapy work? C. Tincati Open questions A. De Luca HCV-related cirrhosis: case presentation and open questions What treatment options for low HCV decay? A.M. Giorgini Open questions M. Pinzani Discussion M. Angelico

7 Preliminary Programme January 27, SESSION 6 Oral communications based on selected abstracts Conveners: A. De Maria, C. Ferrari, A. Saracino SESSION 7 Infection and gender: any differences? Convener: T.A. Santantonio Framing the problem A. d Arminio Monforte Antiviral drug toxicity and pharmacokinetics S. Bonora HIV: which biological differences according to gender? G. Marchetti HCV: natural history of chronic liver disease E. Villa The setting of HIV/HCV coinfection G. Taliani Discussion A. Castagna, M. Lichtner SESSION 8 Awards ceremony and closing remarks A. d Arminio Monforte, C.F. Perno, M. Puoti Milan, Italy January 26-27, 2015

8 orkshop Milan, Italy January 26-27, 2015 Workshop Venue Palazzo delle Stelline Corso Magenta, Milan, Italy Abstract submission Abstract submission instructions and electronic abstract form available online at Submission by not accepted Deadline December 9, 2014 Abstract submission deadline CME Provider and Organizing Secretariat Effetti srl Via Gallarate, Milan, Italy Phone Fax Mail: